Abeona Therapeutics
ABEO
45 hedge funds and large institutions have $26M invested in Abeona Therapeutics in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 8 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 7
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
5% more funds holding
Funds holding: 43 → 45 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less capital invested
Capital invested by funds: $30.1M → $26M (-$4.14M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$973K |
| 2 |
GP
GLG Partners
London,
United Kingdom
|
+$518K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$166K |
| 4 |
Goldman Sachs
New York
|
+$89.2K |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$86.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$451K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$163K |
| 3 |
Millennium Management
New York
|
-$139K |
| 4 |
Morgan Stanley
New York
|
-$102K |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$101K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2.11K | -21 | Closed |
|
ABEO Hedge Fund Activity: Q4 2015 in Review
45 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q4 2015, worth a combined $26M — down 14% from $30.1M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ABEO positions and 8 closed out — a net gain of 2 holders — while 14 added to existing stakes and 7 trimmed.
The largest buyer was Royce & Associates, adding an estimated $973K. The largest seller was Acuta Capital Partners, exiting entirely with an estimated $451K sold.
- 45 institutional investors held Abeona Therapeutics (ABEO) as of Q4 2015, up from 43 in Q3 2015.
- Funds reported $26M of Abeona Therapeutics stock for Q4 2015, down 14% quarter-over-quarter.
- 10 funds opened new Abeona Therapeutics positions in Q4 2015 and 8 closed out, a net change of +2 holders.
- The largest Abeona Therapeutics buyer in Q4 2015 was Royce & Associates, an estimated $973K added.
- The largest Abeona Therapeutics seller in Q4 2015 was Acuta Capital Partners, an estimated $451K sold.
Based on aggregated 13F filings for Q4 2015.